Study on regulatory effect of Danshensu on lipid metabolism of hyperlipidemia rats.
- Author:
Juan CHEN
;
Jun DENG
;
Yu-yan ZHANG
;
Jian-guo LI
;
Fei-yu WU
;
Hai-tong WAN
- Publication Type:Journal Article
- MeSH: Animals; Hyperlipidemias; drug therapy; metabolism; Lactates; pharmacology; Lipid Metabolism; drug effects; Male; Rats; Rats, Sprague-Dawley
- From: China Journal of Chinese Materia Medica 2015;40(2):313-317
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the effect of Danshensu on the lipid metabolism of hyperlipidemic rats.
METHODSixty clean male SD rats were selected. Twelve of them were selected in the basic control group and fed with common foods, and the remaining rats were fed with the high-fat feeds. After the successful modeling, they were randomly divided into the high-fat control group and low dose (10 mg x kg(-1) x d(-1)), medium dose (20 mg x kg(-1) x d(-1)) and high dose (40 mg x kg(-1) x d(-1)) Danshensu (dissolved in saline) groups. Both of the two groups were abdominally injected with the same volume of normal saline once a day for consecutively 30 days. The serum TG, TC, HDL-C and liver ACC1, FAS, HMGR, CPT-I mRNA expressions were detected.
RESULT AND CONCLUSIONDanshensu could inhibit the LDL-C level, timely clear redundant cholesterol and effectively regulate the lipid metablism of hyperlipidemic rats by reducing the TC content, decrease the fatty acid by reducing the FAS mRNA expression, and reduce the synthesis levels of endogenous cholesterol by inhibit the HMGR mRNA expression.